Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Philosophy
Our People
From the CEO
Contact Us
Values and Corporate Governance
Global Ethics & Compliance
Risk & Crisis Management
Corporate Governance
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
We will become a global, values-based, R&D-driven, biopharmaceutical leader
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Clinical Trials
Investigator Initiated Sponsored Research
Areas of Focus
Oncology
Gastroenterology
Rare Diseases
Neuroscience
Plasma-Derived Therapies
Vaccines
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD6
Going Beyond Medicines
Change the World
Healthcare for All
Shared Knowledge for a Better Life for All
Heritage
Keys to Aging Gracefully
Shared Knowledge for a Better Life for All
LEARN MORE
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
Takeda Chair in Global Child Health
SDGs
Takeda Initiative for the Global Fund
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
How We Drive: Sustainable Value
TAKEDA LIFE THEATER
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
Message from the CEO
News Releases
Enter
All
Last 12 months
2019
2018
2017
2016
2015
November 2019
November 6, 2019
11/6/2019
Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
November 6, 2019
11/6/2019
Takeda to Highlight Expanded Portfolio of Products Across Oncology and Hematology at 61st American Society of Hematology (ASH) Annual Meeting
November 5, 2019
11/5/2019
Takeda Unveils New Dengue Vaccine Manufacturing Plant in Germany
November 5, 2019
11/5/2019
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
November 5, 2019
11/5/2019
TAKEDA CONTINUES STRATEGIC DIVESTITURES WITH SALE OF SELECT OTC AND NON-CORE ASSETS TO STADA FOR $660 MILLION USD
October 2019
October 31, 2019
10/31/2019
Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
October 31, 2019
10/31/2019
Takeda Reports Solid Second Quarter FY2019 Results and Raises Profit Guidance for the Full Year
October 22, 2019
10/22/2019
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
October 21, 2019
10/21/2019
Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with UC or CD
1
2
3
4
5
・For legacy Shire information, click here
TOP
